InterMune (nasdaq)ITMN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InterMune (nasdaq)ITMN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Secret_Agent_Man who started this subject	4/26/2001 3:38:54 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) of 508

ITMN CC There was not much new in the CC today. (I did get interrupted during it and will have to listen again.) FWIW, the CC did indicate: - sales running ahead of projections - raising guidance - enrollment in the IPF study at 140 of 260 - 400 off label IPF patients getting the drug - cash at eoq $175 million sufficient through 2003 for needs Ovarian PIII starts 2nd half Liver fibrosis PII starts 2nd half ij PS - If you caught something I missed, or I got something wrong - please contribute.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next